Home » Team


Douglass Given, MD, PhD

Doug is Managing Partner at Health2047 Capital Partners LLC 2018-present. He served as Health2047 Inc.’s Chief Executive from its founding in 2015 until 2018. Doug has spent more than two decades in venture capital as an investment Partner and General Partner at life sciences investor Bay City Capital LLC participating in five sequential life sciences general funds and two sector-specific funds; he was associated with the partnership from 1999-2015. Doug has served on more than 20 public and private boards. He is currently a Director at Health2047 Inc, Board Chair at Arrowhead Pharmaceuticals (NASDAQ:ARWR), Managing Partner at G5 Partners LLC, and serves on the board at First Mile Care Inc, BrYet Health Ltd, Visirna Therapeutics, and Vivaldi Biosciences Inc. Doug received MD and PhD degrees from the University of Chicago, an MBA from the Wharton School at the University of Pennsylvania and was a Clinical and Research Fellow in internal medicine and infectious diseases at Massachusetts General Hospital and Harvard Medical School.

Katie Given, MD, MBA, PhD

Katie is a board certified dermatologist and board-eligible in Micrographic Surgery and Dermatologic Oncology. Her training includes Internal Medicine internship at the University of Chicago Hospitals, Dermatology residency at Yale-New Haven Hospitals, where she served as Chief Resident in her final year, and Mohs Surgery and Cosmetic Fellowship at UCSF. She earned her MD, PhD, and MBA from the University of Chicago. Katie previously served as Resident Representative to the Board of Directors of the American Society of Dermatologic Surgery and as an Innovation Associate at Chicago’s Polsky Center for Entrepreneurship and Innovation, working with the investment teams for faculty new business formation.

Annie Given, BS

Annie formerly served as Director of Finance for Noa Technologies in Berlin. Her expertise is in financial and operations management, particularly for startups. Prior to her 5 years in Germany, she worked with Global BSN in San Francisco and was an investment banking analyst at Stifel in New York City, in the Financial Institutions Group. Annie received her BS in Economics and Mathematics from the University of Southern California. She is a master’s candidate at California Institute of Integral Studies in Integrated Health.

Nick Leeper, MD

Nick is a Professor of Vascular Surgery and Cardiovascular Medicine at Stanford University School of Medicine. Nick’s clinical focus is in vascular medicine and cardiovascular disease. He regularly publishes on related topics in the space, holds two RO1 grants and is an active innovator. Nick is co-founder of Forty Seven, Inc. and Bitterroot. He holds degrees with honors in Chemistry and Medicine from the University of Chicago, and completed his Internal Medicine training at the University of California, San Francisco.

Randy Thompson, MD

permission needed Randy has practiced medicine with Saint Luke’s Cardiovascular Consultants since 1995. His academic history spans, Emory, Massachusetts General Hospital and Harvard Medical School, and The Mayo Clinic. He is member of the Board of Directors of the American Society of Nuclear Cardiology.

Ben Lenail

Ben is a founding officer of ALD Connect, a research consortium focused on the neuro-metabolic disease X-linked adrenoleukodystrophy (X-ALD). Currently, he serves as director of business development at Alta Devices, a solar energy startup in Sunnyvale, CA.

Karl Ronn

permission needed Karl, an engineer, is the managing director of Innovation Portfolio Partners, a Silicon Valley-based firm that helps CEOs and the top management of Fortune 500 companies find and develop new-to-the-world products and services. He is on the advisory boards of Johns Hopkins Bloomberg School of Public Health, the University of Toledo, and Enviroscent.

Cindy Fong-Leeper, JD

Currently an associate general counsel at Facebook, Cindy holds a JD degree from University of Chicago Law School. Prior to joining Facebook in 2011, she served as an associate at Latham & Watkins in San Francisco and Menlo Park for seven years.